Imaging of the appearance time of cerebral blood using [15O]H2O PET for the computation of correct CBF.

Abstract:

BACKGROUND:Quantification of cerebral blood flow (CBF) is important for the understanding of normal and pathologic brain physiology. Positron emission tomography (PET) with H215O (or C15O2) can quantify CBF and apply kinetic analyses, including autoradiography (ARG) and the basis function methods (BFM). These approaches, however, are sensitive to input function errors such as the appearance time of cerebral blood (ATB), known as the delay time. We estimated brain ATB in an image-based fashion to correct CBF by accounting for differences in computed CBF values using three different analyses: ARG and BFM with and without fixing the partition coefficient. METHODS:Subject groups included those with no significant disorders, those with elevated cerebral blood volume, and those with reduced CBF. All subjects underwent PET examination, and CBF was estimated using the three analyses. The ATB was then computed from the differences of the obtained CBF values, and ATB-corrected CBF values were computed. ATB was also estimated for regions of interest (ROIs) of multiple cortical regions. The feasibility of the present method was tested in a simulation study. RESULTS:There were no significant differences in the obtained ATB between the image- and ROI-based methods. Significantly later appearance was found in the cerebellum compared to other brain regions for all groups. In cortical regions where CBF was reduced due to occlusive lesions, the ATB was 0.2 ± 1.2 s, which was significantly delayed relative to the contralateral regions. A simulation study showed that the ATB-corrected CBF was less sensitive to errors in input function, and noise on the tissue curve did not enhance the degree of noise on ATB-corrected CBF image. CONCLUSIONS:This study demonstrates the potential utility of visualizing the ATB in the brain, enabling the determination of CBF with less sensitivity to error in input function.

journal_name

EJNMMI Res

journal_title

EJNMMI research

authors

Kudomi N,Maeda Y,Sasakawa Y,Monden T,Yamamoto Y,Kawai N,Iida H,Nishiyama Y

doi

10.1186/2191-219X-3-41

subject

Has Abstract

pub_date

2013-05-23 00:00:00

pages

41

issue

1

issn

2191-219X

pii

2191-219X-3-41

journal_volume

3

pub_type

杂志文章
  • Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

    abstract:UNLABELLED: BACKGROUND:Iodine-123-β-CIT, a single-photon emission computed tomography (SPECT) ligand for dopamine transporters (DATs), has been used for in vivo studies in humans, monkeys, and rats but has not yet been used extensively in mice. To validate the imaging and analysis methods for preclinical DAT imaging, ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-55

    authors: Pitkonen M,Hippeläinen E,Raki M,Andressoo JO,Urtti A,Männistö PT,Savolainen S,Saarma M,Bergström K

    更新日期:2012-09-29 00:00:00

  • The effect of isoflurane on 18F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation.

    abstract:BACKGROUND:In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer kinetics under study, and the nature of these effects is usually not known. METHOD:We have impleme...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0242-3

    authors: Spangler-Bickell MG,de Laat B,Fulton R,Bormans G,Nuyts J

    更新日期:2016-12-01 00:00:00

  • First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9.

    abstract:BACKGROUND:Gastrin-releasing peptide receptor antagonists have promise in theranostics of several highly incident tumours, including prostate and breast. This study presents the first human dosimetry of 68Ga-NODAGA-MJ9 in the first five consecutive patients with recurrent prostate cancer included in a dual-tracer posit...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0462-9

    authors: Gnesin S,Cicone F,Mitsakis P,Van der Gucht A,Baechler S,Miralbell R,Garibotto V,Zilli T,Prior JO

    更新日期:2018-12-12 00:00:00

  • Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

    abstract:BACKGROUND:Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognost...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0058-y

    authors: Reza M,Bjartell A,Ohlsson M,Kaboteh R,Wollmer P,Edenbrandt L,Trägårdh E

    更新日期:2014-10-17 00:00:00

  • Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images.

    abstract:UNLABELLED: BACKGROUND:In single-photon emission computed tomography (SPECT), attenuation of photon flux in tissue affects quantitative accuracy of reconstructed images. Attenuation maps derived from X-ray computed tomography (CT) can be employed for attenuation correction. The attenuation coefficients as well as regi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-7

    authors: Wu C,Gratama van Andel HA,Laverman P,Boerman OC,Beekman FJ

    更新日期:2013-01-31 00:00:00

  • dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

    abstract:BACKGROUND:Noninvasive multimodality imaging is essential for preclinical evaluation of the biodistribution and pharmacokinetics of radionuclide therapy and for monitoring tumor response. Imaging with nonstandard positron-emission tomography [PET] isotopes such as 124I is promising in that context but requires accurate...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-7

    authors: Anizan N,Carlier T,Hindorf C,Barbet J,Bardiès M

    更新日期:2012-02-13 00:00:00

  • Impact of inherent variability and experimental parameters on the reliability of small animal PET data.

    abstract:BACKGROUND:Noninvasive preclinical imaging methodologies such as small animal positron emission tomography (PET) allow the repeated measurement of the same subject which is generally assumed to reduce the variability of the experimental outcome parameter and to produce more robust results. In this study, the variabilit...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-26

    authors: Martic-Kehl MI,Ametamey SM,Alf MF,Schubiger PA,Honer M

    更新日期:2012-06-09 00:00:00

  • Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.

    abstract:BACKGROUND:Small-cell lung carcinoma (SCLC) is an aggressive malignancy characterised by an early relapse, a tendency towards drug resistance, and a high incidence of metastasis. SCLC cells are of neuroendocrine origin and express high levels of somatostatin receptors; therefore, future treatment might involve targetin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-1-19

    authors: Erlandsson A,Forssell-Aronsson E,Seidal T,Bernhardt P

    更新日期:2011-08-26 00:00:00

  • Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification.

    abstract:BACKGROUND:The molecular features of isocitrate dehydrogenase (IDH) mutation and chromosome 1p and 19q (1p/19q) codeletion status have pivotal role for differentiating gliomas and have been integrated in the World Health Organization (WHO) classification in 2016. Positron emission tomography (PET) with 3'-deoxy-3'-[18F...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00633-1

    authors: Ogawa T,Kawai N,Miyake K,Shinomiya A,Yamamoto Y,Nishiyama Y,Tamiya T

    更新日期:2020-05-07 00:00:00

  • Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization.

    abstract:PURPOSE:We have developed a multi-modal imaging approach for SIRT, combining 99mTc-MAA SPECT/CT and/or 90Y PET, 18F-FDG PET/CT, and contrast-enhanced CBCT for voxel-based dosimetry, as a tool for treatment planning and verification. For radiation dose prediction calculations, a segmentation of the total liver volume an...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0485-x

    authors: Jafargholi Rangraz E,Coudyzer W,Maleux G,Baete K,Deroose CM,Nuyts J

    更新日期:2019-02-20 00:00:00

  • Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging.

    abstract:BACKGROUND:In this work, the in vitro and in vivo stabilities and the pharmacology of HPMA-made homopolymers were studied by means of radiometal-labeled derivatives. Aiming to identify the fewer amount and the optimal DOTA-linker structure that provides quantitative labeling yields, diverse DOTA-linker systems were con...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0372-x

    authors: Eppard E,de la Fuente A,Mohr N,Allmeroth M,Zentel R,Miederer M,Pektor S,Rösch F

    更新日期:2018-02-27 00:00:00

  • Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential.

    abstract:BACKGROUND:PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver disease. Furthermore, we examin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0320-1

    authors: Bak-Fredslund KP,Lykke Eriksen P,Munk OL,Villadsen GE,Keiding S,Sørensen M

    更新日期:2017-08-29 00:00:00

  • Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1).

    abstract:PURPOSE:Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is overexpressed in solid tumours, including prostate cancer (PCa). This st...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00637-x

    authors: Yeh MC,Tse BWC,Fletcher NL,Houston ZH,Lund M,Volpert M,Stewart C,Sokolowski KA,Jeet V,Thurecht KJ,Campbell DH,Walsh BJ,Nelson CC,Russell PJ

    更新日期:2020-05-07 00:00:00

  • Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.

    abstract:BACKGROUND:Targeted alpha therapy (TAT) offers advantages over current β-emitting conjugates for peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors. PRRT with 177Lu-DOTATATE or 90Y-DOTATOC has shown dose-limiting nephrotoxicity due to radiopeptide retention in the proximal tubules. Pharmacological pr...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0240-5

    authors: Chan HS,Konijnenberg MW,Daniels T,Nysus M,Makvandi M,de Blois E,Breeman WA,Atcher RW,de Jong M,Norenberg JP

    更新日期:2016-12-01 00:00:00

  • SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

    abstract:BACKGROUND:Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is 177Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma photons by 177Lu allows ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0262-7

    authors: Gustafsson J,Sundlöv A,Sjögreen Gleisner K

    更新日期:2017-12-01 00:00:00

  • Assessment of regional pulmonary blood flow using 68Ga-DOTA PET.

    abstract:BACKGROUND:In vivo determination of regional pulmonary blood flow (PBF) is a valuable tool for the evaluation of many lung diseases. In this study, the use of 68Ga-DOTA PET for the in vivo quantitative determination of regional PBF is proposed. This methodology was implemented and tested in healthy pigs and validated u...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0259-2

    authors: Velasco C,Mateo J,Santos A,Mota-Cobian A,Herranz F,Pellico J,Mota RA,España S,Ruiz-Cabello J

    更新日期:2017-12-01 00:00:00

  • Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.

    abstract:BACKGROUND:Tenascin-C (TNC), an extracellular matrix glycoprotein, is expressed transiently in distinct areas in association with active tissue remodeling. This study aimed to explore how ischemic postconditioning (PC) affects myocardial expression of TNC and ventricular remodeling using (125)I-labeled anti-TNC antibod...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0100-8

    authors: Taki J,Inaki A,Wakabayashi H,Matsunari I,Imanaka-Yoshida K,Ogawa K,Hiroe M,Shiba K,Yoshida T,Kinuya S

    更新日期:2015-04-02 00:00:00

  • Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.

    abstract:BACKGROUND:In the present study, we used multimodal imaging to investigate biodistribution in rats after intravenous administration of a new 99mTc-labeled delivery system consisting of polymer-shelled microbubbles (MBs) functionalized with diethylenetriaminepentaacetic acid (DTPA), thiolated poly(methacrylic acid) (PMA...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-12

    authors: Barrefelt AA,Brismar TB,Egri G,Aspelin P,Olsson A,Oddo L,Margheritelli S,Caidahl K,Paradossi G,Dähne L,Axelsson R,Hassan M

    更新日期:2013-02-25 00:00:00

  • Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc.

    abstract:BACKGROUND:In molecular imaging and nuclear medicine, theranostic agents that integrate radionuclide pairs are successfully being used for individualized care, which has led to rapidly growing interest in their continued development. These compounds, which are radiolabeled with one radionuclide for imaging and a chemic...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0515-8

    authors: Loveless CS,Radford LL,Ferran SJ,Queern SL,Shepherd MR,Lapi SE

    更新日期:2019-05-16 00:00:00

  • Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy.

    abstract:BACKGROUND:Peptide receptor radionuclide therapy (PRRT) is applied in patients with advanced neuroendocrine tumors. Co-infused amino acids (AA) should prevent nephrotoxicity. The aims of this study were to correlate the incidence of AA-induced hyperkalemia (HK) (≥5.0 mmol/l) and to identify predictors of AA-induced sev...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0074-y

    authors: Lapa C,Werner RA,Bluemel C,Lueckerath K,Muegge DO,Strate A,Haenscheid H,Schirbel A,Allen-Auerbach MS,Bundschuh RA,Buck AK,Herrmann K

    更新日期:2014-12-24 00:00:00

  • 68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617.

    abstract:BACKGROUND:Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer. Treatment with surgery, radioactive iodine (RAI), and TSH suppression is effective in most patients. Five to 15% of patients become RAI refractory and need alternative therapy; however, treatment options are limited. 68Ga-PSMA ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0610-x

    authors: de Vries LH,Lodewijk L,Braat AJAT,Krijger GC,Valk GD,Lam MGEH,Borel Rinkes IHM,Vriens MR,de Keizer B

    更新日期:2020-03-06 00:00:00

  • Non-invasive molecular imaging of inflammatory macrophages in allograft rejection.

    abstract:BACKGROUND:Macrophages represent a critical cell type in host defense, development and homeostasis. The ability to image non-invasively pro-inflammatory macrophage infiltrate into a transplanted organ may provide an additional tool for the monitoring of the immune response of the recipient against the donor graft. We t...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-015-0146-7

    authors: O'Neill AS,Terry SY,Brown K,Meader L,Wong AM,Cooper JD,Crocker PR,Wong W,Mullen GE

    更新日期:2015-12-01 00:00:00

  • Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry.

    abstract:BACKGROUND:Fluorine-18 fluoroethoxybenzovesamicol ([18F]FEOBV) is a radioligand for the selective imaging of the vesicular acetylcholine transporter with positron emission tomography (PET). The current study demonstrates that pathological cortical cholinergic deafferentation can be quantified in vivo with [18F]FEOBV PE...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-70

    authors: Parent MJ,Cyr M,Aliaga A,Kostikov A,Schirrmacher E,Soucy JP,Mechawar N,Rosa-Neto P,Bedard MA

    更新日期:2013-10-09 00:00:00

  • Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients.

    abstract:BACKGROUND:Vagus nerve activation impacts inflammation. Therefore, we hypothesized that vagal nerve stimulation (VNS) influenced arterial wall inflammation as measured by 18F-FDG uptake. RESULTS:Ten patients with left-sided VNS for refractory epilepsy were studied during stimulation (VNS-on) and in the hours after sti...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0567-9

    authors: Boswijk E,Franssen R,Vijgen GHEJ,Wierts R,van der Pol JAJ,Mingels AMA,Cornips EMJ,Majoie MHJM,van Marken Lichtenbelt WD,Mottaghy FM,Wildberger JE,Bucerius J

    更新日期:2019-11-27 00:00:00

  • Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

    abstract:BACKGROUND:Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-DOTATATE) (Cancer Res. 73:12-8, 2013). Moreover, the combination th...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0021-y

    authors: Bison SM,Pool SE,Koelewijn SJ,van der Graaf LM,Groen HC,Melis M,de Jong M

    更新日期:2014-05-30 00:00:00

  • Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer.

    abstract:BACKGROUND:To assess 18-fluorodeoxyglucose (FDG) bowel uptake in patients with differentiated thyroid cancer (DTC) treated with sorafenib. FINDINGS:Visual (5-point scale) and high maximum standard uptake value (SUVmax) semi-quantitative analyses were conducted in 63 positron emission tomography (PET) studies performed...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-18

    authors: Ciappuccini R,Trzepla G,Heutte N,Sevin E,Galais MP,Bardet S

    更新日期:2012-05-07 00:00:00

  • 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.

    abstract:BACKGROUND:Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There is therefore an urgent need for early detection of treatment resistance. METHODS:Isogenic ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00728-9

    authors: Malviya G,Patel R,Salji M,Martinez RS,Repiscak P,Mui E,Champion S,Mrowinska A,Johnson E,AlRasheedi M,Pimlott S,Lewis D,Leung HY

    更新日期:2020-11-25 00:00:00

  • Quantitative performance and optimal regularization parameter in block sequential regularized expectation maximization reconstructions in clinical 68Ga-PSMA PET/MR.

    abstract:BACKGROUND:In contrast to ordered subset expectation maximization (OSEM), block sequential regularized expectation maximization (BSREM) positron emission tomography (PET) reconstruction algorithms can run until full convergence while controlling image quality and noise. Recent studies with BSREM and 18F-FDG PET reporte...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0414-4

    authors: Ter Voert EEGW,Muehlematter UJ,Delso G,Pizzuto DA,Müller J,Nagel HW,Burger IA

    更新日期:2018-07-27 00:00:00

  • Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.

    abstract:BACKGROUND:The use of radiolabeled choline as a positron emission tomography (PET) agent for imaging primary tumors in the prostate has been evaluated extensively over the past two decades. There are, however, conflicting reports of its sensitivity and the relationship between choline PET imaging and disease staging is...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0269-0

    authors: Schaefferkoetter JD,Wang Z,Stephenson MC,Roy S,Conti M,Eriksson L,Townsend DW,Thamboo T,Chiong E

    更新日期:2017-12-01 00:00:00

  • Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy.

    abstract:PURPOSE:To investigate the added value and diagnostic accuracy of 68Ga-PSMA PET/CT versus bone scintigraphy (BS) for bone metastasis detection at the primary staging of prostate cancer (PCa). METHODS:Inclusion criteria involved consecutive patients with newly diagnosed intermediate- to high-risk PCa, who had undergone...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00618-0

    authors: Zacho HD,Ravn S,Afshar-Oromieh A,Fledelius J,Ejlersen JA,Petersen LJ

    更新日期:2020-04-08 00:00:00